Page de couverture de Ophthalmology off the Grid by Eyetube

Ophthalmology off the Grid by Eyetube

Ophthalmology off the Grid by Eyetube

Auteur(s): Eyetube
Écouter gratuitement

À propos de cet audio

Open. Outspoken. It's Ophthalmology off the Grid - an honest look at controversial topics in the field.2024 Bryn Mawr Communications LLC Science
Épisodes
  • A New Era of Presbyopia Drop Therapy
    Sep 16 2025
    Blake Williamson, MD, MPH, invites Steven Dell, MD, to discuss the recent release of a new presbyopia drop—VIZZ (aceclidine ophthalmic solution, 1.44%; Lenz Therapeutics). Dr. Dell outlines why this drop represents a game-changing option for presbyopia therapy. The once-daily drop lasts for 10 hours and results in a sub-2-mm pupil size to achieve significant gains in near vision. They also review the innovation cycle of this product and how patients have responded to the treatment so far.
    Voir plus Voir moins
    31 min
  • Ushering in the Future of Cataract and Refractive Surgery
    Aug 25 2025
    Blake Williamson, MD, MPH, and Gary Wörtz, MD, sit down with Robert Weinstock, MD, to reflect on the field of ophthalmology and how to improve things for the next generation of physicians. They discuss pioneers in the field and how they shaped the cataract and refractive subspecialties into what they are today. Dr. Weinstock also shares perspectives into the fellowship match process and gives advice on how prospective fellows can prepare for interviews. The group also explores the benefits and the value of welcoming younger ophthalmologists into a practice.
    Voir plus Voir moins
    28 min
  • Potential Implications and Benefits of Direct SLT Technology
    Jul 22 2025
    Morgan Micheletti, MD, joins hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, to review the evolution of selective laser trabeculoplasty (SLT) and direct SLT (DSLT), highlighting Dr. Micheletti’s experience as an early adopter of DSLT. Dr. Micheletti shares how DSLT can increase efficiency, improve surgeon comfort with the procedure, and help guide patients in the interventional glaucoma treatment pathway. The group also discusses reimbursement and financial considerations for DSLT.
    Voir plus Voir moins
    37 min
Pas encore de commentaire